{"issuance_frequency":"","notes_translated":{"fr":"Le Relevé des maladies transmissibles au Canada est une publication bilingue et libre d'accès revue par un comité de lecture portant sur la prévention et le contrôle des maladies infectieuses nouvelles et tenaces.","en":"The Canada Communicable Disease Report is a bilingual, open-access, peer-reviewed journal on the prevention and control of emerging and persistent infectious diseases"},"issn":"","imso_approval":"true","isbn":"","creator":"","org_section":{"fr":"","en":""},"jurisdiction":"federal","private":false,"maintainer_email":"open-ouvert@tbs-sct.gc.ca","num_tags":0,"edition":"","frequency":"P1M","data_series_issue_identification":{"fr":"","en":""},"contributor":{"fr":"","en":""},"maintainer":null,"ready_to_publish":"true","id":"e6897c53-a66f-4e36-b319-9a52a5be7e2e","metadata_created":"2021-06-29T06:30:54.242842","subject":["health_and_safety"],"pspc_identification_number":"","metadata_modified":"2021-09-27T20:31:23.043992","author":null,"author_email":null,"geographic_region":[],"portal_release_date":"2021-06-28","digital_object_identifier":"","state":"active","version":null,"keywords":{"fr":["Approche","surveillance","détecter","nouveaux","agrégats","COVID-19","surveillance","contrôler","éclosion","maladie","à coronavirus","2019","syndrome","respiratoire","aigu sévère 2","SRAS-CoV-2","patients","symptomatiques","syndrome","d’immunodéficience","acquise","sida","nouvelles","infections","virus","l’immunodéficience","humaine","VIH","prophylaxie","pré-exposition","PPrE","prévenir","nouvelles infections","Sérovars","Salmonella","enterica","Programme","national","surveillance","maladies","entériques","Tendances","éclosions","d’infections","respiratoires","établissements","soins","de santé","Ontario","implications","estion","des éclosions","non grippales","les établissements","de soins","de longue","durée","les maisons","de retraite","en Ontario","Bioaérosols","provenant","respiration","buccale","mode","de transmission","méconnu","Bioparticules","exhalées","réagir","rapidement","aux signaux","surveillance","vaccins","le vaccin","antigrippal","vivant","atténué","Comité","consultatif","national","immunisation","CCNI","Analyse","environnementale","planification","provinciale","territoriale","programmes","vaccination","Informations","démographiques","Centre","collaboration","nationale","des méthodes","outils","CCNMO","soutenir","la prise","de décisions","fondée","données","probantes","santé publique","au Canada","centres","de collaboration","nationale","santé","publique","CCN","COVID-19","COVID-END","RMTC"],"en":["Population","surveillance","approach","new clusters","COVID-19","control","outbreak","coronavirus disease","2019","severe","acute","respiratory","syndrome","coronavirus 2","SARS-CoV-2","symptomatic","patients","acquired","immunodeficiency","syndrome","AIDS","epidemic","reducing","new human","immunodeficiency","virus","HIV","pre-exposure","prophylaxis","PrEP","prevent","new infections","Salmonella","enterica","National","Enteric","Surveillance","Program","NESP","Trends","respiratory","infection","outbreak","Ontario","healthcare","implications","non-influenza","management","long-term","care","LTC","retirement","homes","RH","Bioaerosols","mouth-breathing","Under-recognized","transmissible mode","Exhaled","bioparticles","National","Advisory","Committee","Immunization","timely","responses","post-market","vaccine","monitoring","signals","live-attenuated","influenza","vaccine","NACI","Environmental","scan","provincial","territorial","planning","COVID-19","vaccination","programs","Demographic","information","Evidence-informed","decision-making","public health","National","Collaborating","Centre","Methods Tools","NCCMT","National Collaborating","Centres","for Public Health","NCC","support","evidence","informed","decision","making","EIDM","COVID-19","Evidence","Network","support","Decision-Making","COVID-END","CCDR"]},"relationships_as_object":[],"creator_user_id":"2dc5a12f-2a6f-4822-8514-165ea6bb05d9","title_translated":{"fr":"RMTC Volume 47-5/6, mai/juin 2021 : Répondre aux nouveaux agrégats de COVID-19","en":"CCDR Volume 47-5/6, May/June 2021: Responding to New Clusters of COVID-19"},"type":"info","resources":[{"cache_last_updated":null,"unique_identifier":"","package_id":"e6897c53-a66f-4e36-b319-9a52a5be7e2e","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"2131e1ca-069b-4369-9202-b07e18c52574","related_relationship":"","name_translated":{"fr":"RMTC Volume 47-5/6, mai/juin 2021 : Répondre aux nouveaux agrégats de COVID-19","en":"CCDR Volume 47-5/6, May/June 2021: Responding to New Clusters of COVID-19"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"CCDR Volume 47-5/6, May/June 2021: Responding to New Clusters of COVID-19","language":["en"],"created":"2021-06-29T06:30:54.349066","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr.html","last_modified":null,"position":0,"revision_id":"2391be17-352f-4fe8-b87c-a7a1c5ecda31","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"e6897c53-a66f-4e36-b319-9a52a5be7e2e","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"30bc617d-d4aa-4f38-a536-a2bba5e272ff","related_relationship":"","name_translated":{"fr":"RMTC Volume 47-5/6, mai/juin 2021 : Répondre aux nouveaux agrégats de COVID-19","en":"CCDR Volume 47-5/6, May/June 2021: Responding to New Clusters of COVID-19"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"CCDR Volume 47-5/6, May/June 2021: Responding to New Clusters of COVID-19","language":["fr"],"created":"2021-06-29T06:30:54.349073","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc.html","last_modified":null,"position":1,"revision_id":"2391be17-352f-4fe8-b87c-a7a1c5ecda31","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"e6897c53-a66f-4e36-b319-9a52a5be7e2e","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"f78e3a77-b2ef-4482-b49f-75e3f735169a","related_relationship":"","name_translated":{"fr":"Surveillance : Approche de surveillance de la population afin de détecter les nouveaux agrégrats de cas de COVID-19 et y répondre","en":"Surveillance: Population surveillance approach to detect and respond to new clusters of COVID-19"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Surveillance: Population surveillance approach to detect and respond to new clusters of COVID-19","language":["en"],"created":"2021-06-29T06:30:54.349076","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2021-47/issue-5-6-may-june-2021/detecting-clusteres-covid-19.html","last_modified":null,"position":2,"revision_id":"2391be17-352f-4fe8-b87c-a7a1c5ecda31","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"e6897c53-a66f-4e36-b319-9a52a5be7e2e","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"c02a2be2-08e9-4945-a4d5-45491999bef9","related_relationship":"","name_translated":{"fr":"Surveillance : Approche de surveillance de la population afin de détecter les nouveaux agrégrats de cas de COVID-19 et y répondre","en":"Surveillance: Population surveillance approach to detect and respond to new clusters of COVID-19"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Surveillance: Population surveillance approach to detect and respond to new clusters of COVID-19","language":["fr"],"created":"2021-06-29T06:30:54.349078","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2021-47/numero-5-6-mai-juin-2021/detection-nouveaux-agregatscovid-19.html","last_modified":null,"position":3,"revision_id":"2391be17-352f-4fe8-b87c-a7a1c5ecda31","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"e6897c53-a66f-4e36-b319-9a52a5be7e2e","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"25abd97f-43ca-4e30-9310-6f0973717d49","related_relationship":"","name_translated":{"fr":"Surveillance : Tendances d’utilisation de la prophylaxie pré-exposition pour le VIH dans huit provinces canadiennes, 2014 à 2018","en":"Surveillance: Trends in HIV pre-exposure prophylaxis use in eight Canadian provinces, 2014–2018"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Surveillance: Trends in HIV pre-exposure prophylaxis use in eight Canadian provinces, 2014–2018","language":["en"],"created":"2021-06-29T06:30:54.349080","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2021-47/issue-5-6-may-june-2021/preexposure-prophylaxis-canada-2014-2018.html","last_modified":null,"position":4,"revision_id":"2391be17-352f-4fe8-b87c-a7a1c5ecda31","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"e6897c53-a66f-4e36-b319-9a52a5be7e2e","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"45c7b600-c06d-4b35-a952-0af24a4ff5dc","related_relationship":"","name_translated":{"fr":"Surveillance : Tendances d’utilisation de la prophylaxie pré-exposition pour le VIH dans huit provinces canadiennes, 2014 à 2018","en":"Surveillance: Trends in HIV pre-exposure prophylaxis use in eight Canadian provinces, 2014–2018"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Surveillance: Trends in HIV pre-exposure prophylaxis use in eight Canadian provinces, 2014–2018","language":["fr"],"created":"2021-06-29T06:30:54.349082","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2021-47/numero-5-6-mai-juin-2021/preexpositions-prophylaxis-canada-2014-2018.html","last_modified":null,"position":5,"revision_id":"2391be17-352f-4fe8-b87c-a7a1c5ecda31","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"e6897c53-a66f-4e36-b319-9a52a5be7e2e","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"ebb73441-439d-47c3-946d-df97b6ba5f16","related_relationship":"","name_translated":{"fr":"Surveillance : Sérovars de Salmonella enterica associés à des bactériémies au Canada, 2006 à 2019","en":"Surveillance: Salmonella enterica serovars associated with bacteremia in Canada, 2006–2019"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Surveillance: Salmonella enterica serovars associated with bacteremia in Canada, 2006–2019","language":["en"],"created":"2021-06-29T06:30:54.349083","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2021-47/issue-5-6-may-june-2021/salmonella-enterica-canada-2006-2019.html","last_modified":null,"position":6,"revision_id":"2391be17-352f-4fe8-b87c-a7a1c5ecda31","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"e6897c53-a66f-4e36-b319-9a52a5be7e2e","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"ca465961-d852-4145-97e5-5f632b6c8244","related_relationship":"","name_translated":{"fr":"Surveillance : Sérovars de Salmonella enterica associés à des bactériémies au Canada, 2006 à 2019","en":"Surveillance: Salmonella enterica serovars associated with bacteremia in Canada, 2006–2019"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Surveillance: Salmonella enterica serovars associated with bacteremia in Canada, 2006–2019","language":["fr"],"created":"2021-06-29T06:30:54.349085","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2021-47/numero-5-6-mai-juin-2021/salmonella-enterica-canada-2006-2019.html","last_modified":null,"position":7,"revision_id":"2391be17-352f-4fe8-b87c-a7a1c5ecda31","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"e6897c53-a66f-4e36-b319-9a52a5be7e2e","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"6af9091e-cbcb-4174-bee6-576948571272","related_relationship":"","name_translated":{"fr":"Éclosion : Au-delà de la grippe : Tendances des éclosions d’infections respiratoires dans les établissements de soins de santé de l’Ontario de 2007 à 2017, et implications pour la gestion des éclosions non grippales","en":"Outbreak: Beyond flu: trends in respiratory infection outbreaks in Ontario healthcare settings from 2007 to 2017, and implications for non-influenza outbreak management"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Outbreak: Beyond flu: trends in respiratory infection outbreaks in Ontario healthcare settings from 2007 to 2017, and implications for non-influenza outbreak management","language":["en"],"created":"2021-06-29T06:30:54.349087","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2021-47/issue-5-6-may-june-2021/respiratory-outbreak-healthcare-ontario-2007-2017.html","last_modified":null,"position":8,"revision_id":"2391be17-352f-4fe8-b87c-a7a1c5ecda31","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"e6897c53-a66f-4e36-b319-9a52a5be7e2e","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"5bdd58d0-e8fa-4e67-97b2-cdcd71f061bf","related_relationship":"","name_translated":{"fr":"Éclosion : Au-delà de la grippe : Tendances des éclosions d’infections respiratoires dans les établissements de soins de santé de l’Ontario de 2007 à 2017, et implications pour la gestion des éclosions non grippales","en":"Outbreak: Beyond flu: trends in respiratory infection outbreaks in Ontario healthcare settings from 2007 to 2017, and implications for non-influenza outbreak management"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Outbreak: Beyond flu: trends in respiratory infection outbreaks in Ontario healthcare settings from 2007 to 2017, and implications for non-influenza outbreak management","language":["fr"],"created":"2021-06-29T06:30:54.349089","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2021-47/numero-5-6-mai-juin-2021/epidemie-respiratoire-soins-sante-ontario-2007-2017.html","last_modified":null,"position":9,"revision_id":"2391be17-352f-4fe8-b87c-a7a1c5ecda31","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"e6897c53-a66f-4e36-b319-9a52a5be7e2e","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"a970d0a8-c266-48bc-952f-4509dda81992","related_relationship":"","name_translated":{"fr":"Aperçu : Bioaérosols provenant de la respiration buccale : mode de transmission méconnu de la COVID-19?","en":"Overview: Bioaerosols from mouth-breathing: Under-recognized transmissible mode in COVID-19?"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Overview: Bioaerosols from mouth-breathing: Under-recognized transmissible mode in COVID-19?","language":["en"],"created":"2021-06-29T06:30:54.349091","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2021-47/issue-5-6-may-june-2021/bioaerosols-covid-19.html","last_modified":null,"position":10,"revision_id":"2391be17-352f-4fe8-b87c-a7a1c5ecda31","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"e6897c53-a66f-4e36-b319-9a52a5be7e2e","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"0351cbe0-84fd-46f8-95d1-7eff14101a2b","related_relationship":"","name_translated":{"fr":"Aperçu : Bioaérosols provenant de la respiration buccale : mode de transmission méconnu de la COVID-19?","en":"Overview: Bioaerosols from mouth-breathing: Under-recognized transmissible mode in COVID-19?"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Overview: Bioaerosols from mouth-breathing: Under-recognized transmissible mode in COVID-19?","language":["fr"],"created":"2021-06-29T06:30:54.349093","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2021-47/numero-5-6-mai-juin-2021/bioaerosols-covid-19.html","last_modified":null,"position":11,"revision_id":"2391be17-352f-4fe8-b87c-a7a1c5ecda31","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"e6897c53-a66f-4e36-b319-9a52a5be7e2e","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"3d489007-4205-4cdd-b47d-20a3287bfa3a","related_relationship":"","name_translated":{"fr":"Aperçu : Démontrer la capacité du Comité consultatif national de l’immunisation à réagir rapidement aux signaux de surveillance des vaccins après leur mise sur le marché : l’expérience du Canada avec le vaccin antigrippal vivant atténué","en":"Overview: Demonstrating the capacity of the National Advisory Committee on Immunization for timely responses to post-market vaccine monitoring signals: Canada’s experience with the live-attenuated influenza vaccine"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Overview: Demonstrating the capacity of the National Advisory Committee on Immunization for timely responses to post-market vaccine monitoring signals: Canada’s experience with the live-attenuated influenza vaccine","language":["en"],"created":"2021-06-29T06:30:54.349095","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2021-47/issue-5-6-may-june-2021/national-advisory-committee-immunization-recommendations-post-market-vaccine-live-attenuated-influenza-vaccine.html","last_modified":null,"position":12,"revision_id":"2391be17-352f-4fe8-b87c-a7a1c5ecda31","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"e6897c53-a66f-4e36-b319-9a52a5be7e2e","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"65fed286-1388-4a4a-aade-93a45279bc2e","related_relationship":"","name_translated":{"fr":"Aperçu : Démontrer la capacité du Comité consultatif national de l’immunisation à réagir rapidement aux signaux de surveillance des vaccins après leur mise sur le marché : l’expérience du Canada avec le vaccin antigrippal vivant atténué","en":"Overview: Demonstrating the capacity of the National Advisory Committee on Immunization for timely responses to post-market vaccine monitoring signals: Canada’s experience with the live-attenuated influenza vaccine"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Overview: Demonstrating the capacity of the National Advisory Committee on Immunization for timely responses to post-market vaccine monitoring signals: Canada’s experience with the live-attenuated influenza vaccine","language":["fr"],"created":"2021-06-29T06:30:54.349096","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2021-47/numero-5-6-mai-juin-2021/recommandations-comite-consultatif-national-immunisation-concernant-post-commercialisation-vaccin-vivant-attenue-contre-grippe.html","last_modified":null,"position":13,"revision_id":"2391be17-352f-4fe8-b87c-a7a1c5ecda31","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"e6897c53-a66f-4e36-b319-9a52a5be7e2e","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"6ad24110-29e5-4194-a45f-fa4322bb7d18","related_relationship":"","name_translated":{"fr":"Étude qualitative : Analyse environnementale de la planification provinciale et territoriale aux fins des programmes de vaccination contre la COVID-19 au Canada","en":"Qualitative studies: Environmental scan of provincial and territorial planning for COVID-19 vaccination programs in Canada"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Qualitative studies: Environmental scan of provincial and territorial planning for COVID-19 vaccination programs in Canada","language":["en"],"created":"2021-06-29T06:30:54.349098","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2021-47/issue-5-6-may-june-2021/covid-19-provincial-territorial-vaccination-programs-canada.html","last_modified":null,"position":14,"revision_id":"2391be17-352f-4fe8-b87c-a7a1c5ecda31","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"e6897c53-a66f-4e36-b319-9a52a5be7e2e","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"73ffad56-81f1-441d-a246-a059c0df3209","related_relationship":"","name_translated":{"fr":"Étude qualitative : Analyse environnementale de la planification provinciale et territoriale aux fins des programmes de vaccination contre la COVID-19 au Canada","en":"Qualitative studies: Environmental scan of provincial and territorial planning for COVID-19 vaccination programs in Canada"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Qualitative studies: Environmental scan of provincial and territorial planning for COVID-19 vaccination programs in Canada","language":["fr"],"created":"2021-06-29T06:30:54.349100","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2021-47/numero-5-6-mai-juin-2021/covid-19-programmes-vaccination-provinciaux-territoriaux-canada.html","last_modified":null,"position":15,"revision_id":"2391be17-352f-4fe8-b87c-a7a1c5ecda31","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"e6897c53-a66f-4e36-b319-9a52a5be7e2e","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"4e272398-d8a3-4c3c-a54b-55f6d5daaab5","related_relationship":"","name_translated":{"fr":"Série : Le Centre de collaboration nationale des méthodes et outils (CCNMO) : soutenir la prise de décisions fondée sur des données probantes en santé publique au Canada","en":"Series: The National Collaborating Centre for Methods and Tools (NCCMT): Supporting evidence-"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Series: The National Collaborating Centre for Methods and Tools (NCCMT): Supporting evidence-","language":["en"],"created":"2021-06-29T06:30:54.349102","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2021-47/issue-5-6-may-june-2021/evidence-informed-decision-making-national-collaborating-centre-methods-tools.html","last_modified":null,"position":16,"revision_id":"2391be17-352f-4fe8-b87c-a7a1c5ecda31","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"e6897c53-a66f-4e36-b319-9a52a5be7e2e","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"ac18b95b-3677-4103-86ee-de5ec053b284","related_relationship":"","name_translated":{"fr":"Série : Le Centre de collaboration nationale des méthodes et outils (CCNMO) : soutenir la prise de décisions fondée sur des données probantes en santé publique au Canada","en":"Series: The National Collaborating Centre for Methods and Tools (NCCMT): Supporting evidence-"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Series: The National Collaborating Centre for Methods and Tools (NCCMT): Supporting evidence-","language":["fr"],"created":"2021-06-29T06:30:54.349104","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2021-47/numero-5-6-mai-juin-2021/prise-decision-fondee-donnees-probants-centre-collaboration-nationale-methodes-outils.html","last_modified":null,"position":17,"revision_id":"2391be17-352f-4fe8-b87c-a7a1c5ecda31","resource_type":"website"}],"place_of_publication":[],"num_resources":18,"tags":[],"spatial":"","collection":"publication","org_title_at_publication":{"fr":"Agence de la santé publique du Canada","en":"Public Health Agency of Canada"},"date_published":"2021-06-10 00:00:00","issuance":"","groups":[],"license_id":"ca-ogl-lgo","data_series_name":{"fr":"","en":""},"relationships_as_subject":[],"license_title":"Open Government Licence - Canada","restrictions":"unrestricted","organization":{"description":"","created":"2016-09-23T17:25:57.068700","title":"Public Health Agency of Canada | Agence de la santé publique du Canada","name":"phac-aspc","is_organization":true,"state":"active","image_url":"","revision_id":"96161da6-edc7-4d1d-99e0-baac9df7b3b9","type":"organization","id":"1C71053B-AA64-4646-956B-41631C396018","approval_status":"approved"},"name":"e6897c53-a66f-4e36-b319-9a52a5be7e2e","isopen":false,"additional_notes":{"fr":"","en":""},"departmental_identification_number":"","notes":"The Canada Communicable Disease Report is a bilingual, open-access, peer-reviewed journal on the prevention and control of emerging and persistent infectious diseases","owner_org":"1C71053B-AA64-4646-956B-41631C396018","program_page_url":{"fr":"","en":""},"url":null,"audience":[],"gc_catalogue_number":"","license_url":"http://open.canada.ca/en/open-government-licence-canada","series_publication_dates":{"fr":"","en":""},"title":"CCDR Volume 47-5/6, May/June 2021: Responding to New Clusters of COVID-19","revision_id":"2391be17-352f-4fe8-b87c-a7a1c5ecda31"}